A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Radiology

Background:

• Superparamagnetic iron oxide (SPIO) colloids are used as magnetic resonance (MR) contrast agents.
• Current SPIO agents are cleared by the reticuloendothelial system (RES), limiting their applications.
• Targeted delivery and clearance mechanisms are needed for novel MR contrast agents.

Purpose of the Study:

• To synthesize and characterize a novel surface-functionalized SPIO colloid with a distinct clearance mechanism.
• To evaluate the in vivo behavior and efficacy of this SPIO colloid as a hepatic selective (HS) MR contrast agent.
• To investigate the potential for receptor-mediated endocytosis in SPIO colloid clearance.

Main Methods:

• Synthesis of surface-functionalized SPIO colloid.
• In vivo studies in rats to assess vascular clearance, biodistribution, and MR imaging enhancement.
• Administration of asialofetuin and fetuin to investigate clearance inhibition.
• Measurement of hepatic relaxation rates to assess RES uptake.

Main Results:

• The synthesized SPIO colloid's clearance was inhibited by asialofetuin, but not fetuin.
• Unlike conventional SPIOs, this agent was not cleared by the macrophage-monocyte phagocytic system.
• The agent selectively increased hepatic relaxation rates, indicating hepatic targeting.
• MR imaging of the liver was enhanced at a dose of 20 µmol Fe/kg.
• No acute toxicity was observed at a high dose of 1800 µmol Fe/kg.

Conclusions:

• Surface-functionalized SPIO colloids can be designed for clearance via receptor-mediated endocytosis, specifically targeting the asialoglycoprotein receptor.
• This novel HS MR contrast agent demonstrates potential for improved MR imaging of the liver.
• The findings suggest a new paradigm for developing MR contrast agents based on targeted cellular uptake mechanisms.